XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 100 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $964,246 | +25.2% | 428,554 | +23.0% | 0.00% | – |
| Q1 2024 | $770,271 | -11.5% | 348,539 | -5.9% | 0.00% | – |
| Q4 2023 | $870,539 | +13.3% | 370,442 | -10.3% | 0.00% | – |
| Q3 2023 | $768,074 | -30.9% | 412,943 | -2.7% | 0.00% | – |
| Q2 2023 | $1,111,807 | +65.9% | 424,354 | +3.2% | 0.00% | – |
| Q1 2023 | $670,246 | +22.7% | 411,194 | +0.1% | 0.00% | – |
| Q4 2022 | $546,372 | -14.9% | 410,806 | -0.1% | 0.00% | – |
| Q3 2022 | $642,000 | +10.9% | 411,113 | +9.3% | 0.00% | – |
| Q2 2022 | $579,000 | +136.3% | 376,001 | +292.2% | 0.00% | – |
| Q1 2022 | $245,000 | -12.8% | 95,870 | 0.0% | 0.00% | – |
| Q4 2021 | $281,000 | – | 95,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,113,348 | $11,505,033 | 58.31% |
| Rosalind Advisors, Inc. | 3,120,170 | $7,020,382 | 5.40% |
| MPM BioImpact LLC | 4,830,526 | $10,868,684 | 1.69% |
| Knott David M Jr | 820,000 | $1,845 | 0.74% |
| CenterBook Partners LP | 1,465,875 | $3,298,219 | 0.20% |
| Redmile Group, LLC | 1,046,587 | $2,354,821 | 0.14% |
| Alpine Global Management, LLC | 300,000 | $675,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 605,663 | $1,363 | 0.10% |
| Invenomic Capital Management LP | 592,078 | $1,332,176 | 0.06% |
| Powell Investment Advisors, LLC | 50,000 | $112,500 | 0.06% |